SOPH — Sophia Genetics SA Cashflow Statement
0.000.00%
Last trade - 00:00- $202.50m
- $152.30m
- $65.17m
- 41
- 27
- 37
- 27
Annual cashflow statement for Sophia Genetics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -41.2 | -73.5 | -87.6 | -78.5 | -61.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4.01 | 7.73 | 14.8 | 17.2 | 11.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.09 | 4.23 | -2.89 | 4.39 | -1.61 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -31.7 | -57.9 | -70.1 | -48.6 | -42.8 |
| Capital Expenditures | -3.2 | -6.67 | -10.4 | -9.23 | -8.18 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -21.1 | -50.3 | 52.4 | 17.5 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -24.3 | -56.9 | 42 | 8.32 | -8.18 |
| Financing Cash Flow Items | — | 25.7 | 0 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 107 | 238 | -1.57 | -2.82 | 11.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 56.6 | 118 | -31.7 | -38.1 | -43 |